FOXP3 was mainly expressed in Tregs and plays a role in promoting cancer, suggesting that the infiltration of FOXP3-positive Tregs promotes the occurrence and development of NSCLC and provides a new target for its immunotherapy. The gene discussed is FOXP3; the disease is cancer.